EKTA.B

48.48

-3.62%↓

EKTA.B

48.48

-3.62%↓

EKTA.B

48.48

-3.62%↓

EKTA.B

48.48

-3.62%↓

EKTA.B

48.48

-3.62%↓

Search

Alligator Bioscience AB

Closed

0.005 -16.67

Overview

Share price change

24h

Current

Min

0.005

Max

0.005

Key metrics

By Trading Economics

Income

1.9M

-60M

Sales

40M

42M

EPS

-0.006

Profit margin

-143.826

Employees

46

EBITDA

56M

-3.8M

Market Stats

By TradingEconomics

Market Cap

120M

Previous open

16.68

Previous close

0.005

Alligator Bioscience AB Chart

Past performance is not a reliable indicator of future results.

Related News

4 Apr 2025, 22:38 UTC

Hot Stocks

Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies

5 Apr 2025, 09:30 UTC

Earnings

Elon Musk's Mr. Fix-It Takes Center Stage During a Really Bad Week -- WSJ

5 Apr 2025, 01:00 UTC

Acquisitions, Mergers, Takeovers

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ

5 Apr 2025, 01:00 UTC

Acquisitions, Mergers, Takeovers

How BlackRock's Larry Fink Won Over Donald Trump -- WSJ -2-

4 Apr 2025, 21:53 UTC

Market Talk

Maxeon's Supply Chain Move at Critical Time for Solar Panel Cos -- Market Talk

4 Apr 2025, 21:44 UTC

Top News
Acquisitions, Mergers, Takeovers

Trump Grants 75-Day Extension to Reach TikTok Deal -- 3rd Update

4 Apr 2025, 21:00 UTC

Top News

Americans Were Souring on Trump's Economic Plans Even Before Tariff Bloodbath -- WSJ

4 Apr 2025, 20:52 UTC

Market Talk

Peloton Likely to Escape Tariffs Unscathed -- Market Talk

4 Apr 2025, 20:52 UTC

Top News

Trump Can Cut Teacher-Training Programs For Now, Supreme Court Says -- WSJ

4 Apr 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 Apr 2025, 20:48 UTC

Top News

The Score: Nike, Apple, Stellantis and More Stocks That Defined the Week -- WSJ

4 Apr 2025, 20:45 UTC

Top News

Hiring Defied Expectations in March, With 228,000 New Jobs -- 6th Update

4 Apr 2025, 20:32 UTC

Top News

Dow Tumbles 2,000 Points, Bonds Rally After China Retaliates Against Trump Tariffs -- WSJ

4 Apr 2025, 20:21 UTC

Top News

China Hits Back at Trump With Sweeping Tariffs on All U.S. Goods -- Update

4 Apr 2025, 20:00 UTC

Top News

Republicans March Ahead on Trump's Tax Cuts as Tariffs Kick In -- WSJ

4 Apr 2025, 19:51 UTC

Market Talk

Dollar Recovers While Recession Fears Grip Wall Street -- Market Talk

4 Apr 2025, 19:37 UTC

Top News

Trump's Team is Getting the Bond Rally It Wanted. But for the Wrong Reasons. -- WSJ

4 Apr 2025, 19:32 UTC

Market Talk

Oil Selloff Continues as China Responds to U.S. Tariffs -- Market Talk

4 Apr 2025, 19:28 UTC

Top News

U.S. Stocks Fall Further After China Retaliates Against Trump Tariffs -- Update

4 Apr 2025, 19:15 UTC

Market Talk

Costco Gold, Membership Fees Could Help Cushion from Tariff Costs -- Market Talk

4 Apr 2025, 19:12 UTC

Top News

Powell Warns of Higher Prices, Weaker Growth After Tariff Plan -- 3rd Update

4 Apr 2025, 19:11 UTC

Market Talk

U.S. Natural Gas Falls as Global Selloff Continues -- Market Talk

4 Apr 2025, 19:09 UTC

Market Talk

Mexican Stocks, Peso Tumble as Global Rout Continues -- Market Talk

4 Apr 2025, 19:09 UTC

Top News

Trump Grants 75-Day Extension to Reach TikTok Deal -- Second Update

4 Apr 2025, 19:00 UTC

Market Talk

Fed Has Limited Options to Counter Tariffs -- Market Talk

4 Apr 2025, 18:53 UTC

Market Talk

Brace for Trump's Tariff Order to Remain in Place for Extended Period -- Market Talk

4 Apr 2025, 18:51 UTC

Market Talk

Morgan Stanley Analysts Outline Paths to Recession -- Market Talk

4 Apr 2025, 18:44 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4 Apr 2025, 18:44 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 Apr 2025, 18:44 UTC

Market Talk

Tariffs Won't Achieve What Trump Wants, Morgan Stanley Says -- Market Talk

Peer Comparison

Price change

Alligator Bioscience AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Alligator Bioscience AB

Alligator Bioscience AB (publ), a research-based biotechnology company, develops antibody-based pharmaceuticals for cancer treatment in Sweden. The company's product portfolio includes Mitazalimab, a stimulatory antibody that targets CD40, which is in phase 2 clinical trial for the treatment of solid metastatic tumors, including pancreatic cancer; and ATOR-4066, tumor-directed bispecific antibody, developed using Neo-X-Prime technology platform for immunotherapy, which is in preclinical stage. It also offers ALG.APV-527, a bispecific antibody that targets the 4-1BB and 5T4 molecules, which is in phase 1 clinical trial for the treatment of solid metastatic tumors; and ATOR-1017, an immunostimulatory antibody, which is in phase 1 clinical trial for the treatment of metastatic cancer. In addition, the company develops products using its technology platforms, including ALLIGATOR-GOLD, a proprietary human antibody library that contains approximately 60 billion unique antibody fragments; ALLIGATOR-FAB, which is built on multiple scaffolds with optimal drug development properties to further increase the structural diversity of generated antibodies; FIND, a molecular evolution technology for optimization of antibodies and other proteins; and RUBY, a bispecific antibody format. Further, it has collaboration and out-licensing agreements with Aptevo Therapeutics, Inc.; Orion Corporation.; MacroGenics, Inc.; Biotheus Inc.; BioArctic AB; and Abclon Inc. The company was founded in 2000 and is headquartered in Lund, Sweden.